4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Toronto
Toronto, Ontario, Canada
- University of California, San Diego (ucsd)
San Diego, California, United States
- University of California, San Francisco (ucsf)
San Francisco, California, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Harvard University - Massachusetts General Hospital
Charlestown, Massachusetts, United States
- Mayo Clinic - Rochester
Rochester, Minnesota, United States
- Columbia University
New York, New York, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2016
- Primary completion
- 28 Feb 2024
- Completion
- 28 Feb 2024
- Last update posted
- 13 Apr 2025
- Registered enrollment
- 293
- Registry id
- NCT02966145
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.